Quick Takeaways
- OPKO HEALTH, INC. filed SCHEDULE 13G for Entera Bio Ltd. Ordinary Shares Nominal value of NIS 0.0000769 per share (ENTX).
- Disclosed ownership: 8.1%.
- Date of event: 16 Mar 2025.
OPKO HEALTH, INC. - 16 Mar 2025 SCHEDULE 13G Report for Entera Bio Ltd. Ordinary Shares Nominal value of NIS 0.0000769 per share (ENTX)
- Filing Manager
- OPKO HEALTH, INC.
- Reporting Manager
- OPKO HEALTH, INC.
- Symbol
- ENTX
- Shares outstanding
- 45,496,617 shares
- Disclosed Ownership
- 3,685,226 shares
- Ownership
- 8.1%
- Form type
- SCHEDULE 13G
- Filing time
- 02 Apr 2025, 18:51:11 UTC
- Date of event
- 16 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"OPKO HEALTH, INC. disclosed 8.1% ownership in Entera Bio Ltd. Ordinary Shares Nominal value of NIS 0.0000769 per share (ENTX) on 16 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 02 Apr 2025, 18:51.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| OPKO HEALTH, INC. | 8.1% | 3,685,226 | 3,685,226 | 0 | /s/ Steven D. Rubin | Executive Vice President - Administration |